Search Videos and More
News
A Common Cancer at an Uncommon Age
Colorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer death in individuals aged 20-49 in the U.S. by the year 2030.
News
Studies of Novel Therapeutic Approaches Highlighted During Colorectal Cancer Awareness Month at Dana-Farber
Colorectal cancer is the 3rd most common cancer among men and women of all ages in the US and is on track to be the leading cause of cancer death in adults under 50 by 2030.
News
Immunotherapy With Two Novel Drugs Shows Activity in Colorectal Cancer
A combination of two next-generation immunotherapy drugs has shown promising clinical activity in treating patients with refractory metastatic colorectal cancer, a disease which has not previously responded well to immunotherapies, according to a Dana-Farber Cancer Institute researcher.
News
Online Testing Tool Identifies People Likely to Benefit from Genetic Testing for Inherited Risk for Certain Cancers
An online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people who should undergo testing for inherited genetic changes that raise the risk of developing certain cancers, a new study shows.
Video
Young-Onset Colorectal Cancer Center Gut Instincts Series: Best Practices for Symptom Management
Dana-Farber’s Young-Onset Colorectal Cancer Center's Gut Instincts series continued on Tuesday, January 25 with an educational workshop on Best Practices for Symptom Management.
Video
Young-Onset Colorectal Cancer Center Annual Forum Research Keynote
At the Young-Onset Colorectal Cancer Center's third annual Patient and Family Forum, a Research Keynote lead by Jonathan Nowak, MD, PhD and Benjamin Schlechter, MD, discussed immunotherapy and CAR-T cell therapy in young-onset colorectal cancer.
News
Dana-Farber Researchers Present Findings at 2022 ASCO Genitourinary Cancers Symposium
Dana-Farber Cancer Institute researchers presented important research studies during the 2022 ASCO Genitourinary (GU) Cancers Symposium, that took place from February 17-19, both virtually and in-person in San Francisco.
News
A Case of Mistaken Identity: Researchers Unmask Cellular Source of Barrett’s Esophagus
Two recent studies by Dana-Farber Cancer Institute scientists correct a longstanding misconception about the origins of Barrett’s esophagus, and in doing so may point to new avenues of treatment or prevention to lower the risk of esophageal cancer.
News
Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
News
New Research Initiative Launches for All Patients Ever Diagnosed with Colorectal Cancer
Count Me In, a nonprofit cancer research initiative, is inviting all patients across the United States and Canada who have ever been diagnosed with colorectal cancer to participate in research and help drive new discoveries related to this disease.
News
Vitamin D May Protect Against Young-Onset Colorectal Cancer
Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according to the first study to show such an association.
News
Red Meat Consumption May Promote DNA Damage-associated Mutations in Patients with Colorectal Cancer
Genetic mutations indicative of DNA damage were associated with high red meat consumption and increased cancer-related mortality in patients with colorectal cancer, according to a study led by Dana-Farber Cancer Institute researchers and published in Cancer Discovery, a journal of the American Association for Cancer Research.